Mark Mallon Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Mallon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Mallon. Mark Mallon is Chief Executive Officer in NEOGENOMICS INC ($NEO) and Chief Executive Officer in IRONWOOD PHARMACEUTICALS INC ($IRWD) and Executive Senior Advisor in IRONWOOD PHARMACEUTICALS INC ($IRWD).
Latest Insider Trading Transactions of Mark Mallon
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2021 | NEO | NEOGENOMICS INC | Mallon Mark | Chief Executive Off ... | Option Exercise | A | 49.34 | 151,016 | 7,451,129 | 151,016 | |
| Apr 21 2021 | NEO | NEOGENOMICS INC | Mallon Mark | Chief Executive Off ... | Grant | A | 0.00 | 55,736 | 0 | 55,736 | 0 to 55.7 K |
| Mar 02 2021 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 9.11 | 22,582 | 205,722 | 470,605 | 493.2 K to 470.6 K (-4.58 %) |
| Mar 02 2021 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 9.11 | 8,093 | 73,727 | 493,187 | 501.3 K to 493.2 K (-1.61 %) |
| May 13 2020 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 10.35 | 23,206 | 240,182 | 501,280 | 524.5 K to 501.3 K (-4.42 %) |
| Feb 25 2020 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 11.25 | 1 | 11 | 303,425 | 303.4 K to 303.4 K (0.00 %) |
| Feb 25 2020 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 11.63 | 7,983 | 92,842 | 303,426 | 311.4 K to 303.4 K (-2.56 %) |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Option Exercise | A | 14.02 | 423,049 | 5,931,147 | 423,049 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Option Exercise | A | 10.97 | 21,203 | 232,597 | 192,729 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Grant | A | 0.00 | 206,873 | 0 | 311,409 | 104.5 K to 311.4 K (+197.90 %) |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Grant | A | 0.00 | 11,500 | 0 | 104,536 | 93 K to 104.5 K (+12.36 %) |
| Jan 11 2019 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Executive Senior Ad ... | Option Exercise | A | 12.32 | 171,526 | 2,113,200 | 171,526 | |
| Jan 11 2019 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Executive Senior Ad ... | Grant | A | 0.00 | 93,036 | 0 | 93,036 | 0 to 93 K |
Page: 1